NEW YORK (GenomeWeb News) – Stocks in the GenomeWeb Daily News Index continued their rebound for the second straight month, with Affymetrix rising sharply for the second time in as many months. Meanwhile, Sequenom's shares tumbled on the last day of the month after the firm announced that it would delay the launch of its SEQureDx Down syndrome test due to company employees mishandling R&D test data and results.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.